A pharmaceutical facility may be built on schedule and still be months away from commercial production. The cause is often issues that originated much earlier in the project lifecycle, surfacing only once commissioning begins.
Equipment documentation gaps, supplier quality concerns, installation deficiencies and incomplete testing activities can all jeopardize operational readiness and delay qualification.
The cost of discovering problems too late
Modern pharmaceutical projects rely on complex equipment, critical utilities, computerized systems and global supply chains. When quality and compliance requirements are not incorporated from the beginning, problems can accumulate unnoticed.
A missing factory acceptance test, an installation deviation, incomplete supplier documentation or insufficient quality oversight may appear manageable in isolation. Together, however, they can create significant delays, increase qualification workloads and drive costly rework.
Early supplier assessments, vendor inspections, expediting activities and construction quality assurance help resolve these issues before they impact commissioning schedules.
Building quality into every project stage
Commissioning and qualification represent the point where project execution meets regulatory compliance. Equipment and systems must function correctly while demonstrating that they meet defined GMP and operational requirements.
A coordinated approach that combines supplier assurance, construction quality oversight, commissioning, qualification and validation (CQV) helps bridge the gap between engineering and quality teams. Involving operations personnel early and maintaining complete, inspection-ready documentation further supports a smoother transition to commercial manufacturing.
